InMode Ltd. (NASDAQ: INMD) Stock Competitors & Peer Comparison
See INMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for INMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INMD | $15.31 | +1.26% | 880M | 10.63 | $1.44 | N/A |
| ABT | $107.81 | -0.14% | 186.5B | 20.69 | $5.21 | +2.31% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $339.03 | +0.47% | 130B | 25.32 | $13.39 | +1.03% |
| MDT | $87.16 | +1.44% | 111.6B | 15.76 | $5.53 | +3.29% |
| BSX | $49.31 | +0.02% | 73.3B | 15.91 | $3.10 | N/A |
| EW | $89.72 | +0.45% | 51.7B | 33.23 | $2.70 | N/A |
| DXCM | $84.75 | +2.08% | 32B | 36.37 | $2.33 | N/A |
| RMD | $211.94 | -5.06% | 30.7B | 19.68 | $10.77 | +1.15% |
| PHG | $26.73 | +1.52% | 26.1B | 15.28 | $1.75 | +3.70% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
INMD vs ABT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ABT has a market cap of 186.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ABT trades at $107.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ABT's P/E ratio is 20.69. In terms of profitability, INMD's ROE is +0.13%, compared to ABT's ROE of +0.11%. Regarding short-term risk, INMD is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
INMD vs BSX-PA Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, INMD's ROE is +0.13%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, INMD is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
INMD vs SYK Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SYK has a market cap of 130B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SYK trades at $339.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SYK's P/E ratio is 25.32. In terms of profitability, INMD's ROE is +0.13%, compared to SYK's ROE of +0.16%. Regarding short-term risk, INMD is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for INMD.Check SYK's competition here
Medtronic plc (NYSE: MDT)
INMD vs MDT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, MDT has a market cap of 111.6B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while MDT trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas MDT's P/E ratio is 15.76. In terms of profitability, INMD's ROE is +0.13%, compared to MDT's ROE of +0.10%. Regarding short-term risk, INMD is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
INMD vs BSX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BSX has a market cap of 73.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BSX trades at $49.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BSX's P/E ratio is 15.91. In terms of profitability, INMD's ROE is +0.13%, compared to BSX's ROE of +0.15%. Regarding short-term risk, INMD is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
INMD vs EW Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while EW trades at $89.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas EW's P/E ratio is 33.23. In terms of profitability, INMD's ROE is +0.13%, compared to EW's ROE of +0.10%. Regarding short-term risk, INMD is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for INMD.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
INMD vs DXCM Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, DXCM has a market cap of 32B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while DXCM trades at $84.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas DXCM's P/E ratio is 36.37. In terms of profitability, INMD's ROE is +0.13%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, INMD is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for INMD.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
INMD vs RMD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, RMD has a market cap of 30.7B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while RMD trades at $211.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas RMD's P/E ratio is 19.68. In terms of profitability, INMD's ROE is +0.13%, compared to RMD's ROE of +0.24%. Regarding short-term risk, INMD is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
INMD vs PHG Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PHG trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PHG's P/E ratio is 15.28. In terms of profitability, INMD's ROE is +0.13%, compared to PHG's ROE of +0.10%. Regarding short-term risk, INMD is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for INMD.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
INMD vs ZBH Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ZBH has a market cap of 18.7B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ZBH trades at $96.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ZBH's P/E ratio is 11.38. In terms of profitability, INMD's ROE is +0.13%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, INMD is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
INMD vs ABMD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ABMD's P/E ratio is 65.36. In terms of profitability, INMD's ROE is +0.13%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, INMD is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for INMD.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
INMD vs PEN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PEN trades at $324.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PEN's P/E ratio is 84.77. In terms of profitability, INMD's ROE is +0.13%, compared to PEN's ROE of +0.11%. Regarding short-term risk, INMD is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for INMD.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
INMD vs SNN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SNN's P/E ratio is 14.16. In terms of profitability, INMD's ROE is +0.13%, compared to SNN's ROE of +0.12%. Regarding short-term risk, INMD is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for INMD.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
INMD vs SWAV Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SWAV's P/E ratio is 78.76. In terms of profitability, INMD's ROE is +0.13%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, INMD is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for INMD.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
INMD vs ALGN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ALGN trades at $173.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ALGN's P/E ratio is 15.83. In terms of profitability, INMD's ROE is +0.13%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, INMD is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
INMD vs GMED Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while GMED trades at $82.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas GMED's P/E ratio is 18.56. In terms of profitability, INMD's ROE is +0.13%, compared to GMED's ROE of +0.12%. Regarding short-term risk, INMD is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for INMD.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
INMD vs GKOS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while GKOS trades at $180.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas GKOS's P/E ratio is -209.45. In terms of profitability, INMD's ROE is +0.13%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, INMD is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for INMD.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
INMD vs PODD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PODD has a market cap of 9.8B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PODD trades at $141.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PODD's P/E ratio is 24.05. In terms of profitability, INMD's ROE is +0.13%, compared to PODD's ROE of +0.27%. Regarding short-term risk, INMD is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
INMD vs BIO-B Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BIO-B trades at $349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BIO-B's P/E ratio is 103.54. In terms of profitability, INMD's ROE is +0.13%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, INMD is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for INMD.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
INMD vs BIO Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BIO has a market cap of 9.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BIO trades at $352.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BIO's P/E ratio is 38.00. In terms of profitability, INMD's ROE is +0.13%, compared to BIO's ROE of +0.03%. Regarding short-term risk, INMD is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
INMD vs MASI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas MASI's P/E ratio is 44.43. In terms of profitability, INMD's ROE is +0.13%, compared to MASI's ROE of +0.09%. Regarding short-term risk, INMD is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for INMD.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
INMD vs BRKR Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BRKR trades at $53.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BRKR's P/E ratio is 26.84. In terms of profitability, INMD's ROE is +0.13%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, INMD is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
INMD vs NARI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas NARI's P/E ratio is -59.24. In terms of profitability, INMD's ROE is +0.13%, compared to NARI's ROE of -0.00%. Regarding short-term risk, INMD is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for INMD.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
INMD vs ITGR Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ITGR trades at $125.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ITGR's P/E ratio is 19.72. In terms of profitability, INMD's ROE is +0.13%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, INMD is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for INMD.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
INMD vs IRTC Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while IRTC trades at $127.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas IRTC's P/E ratio is -199.75. In terms of profitability, INMD's ROE is +0.13%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, INMD is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for INMD.Check IRTC's competition here
LivaNova PLC (NASDAQ: LIVN)
INMD vs LIVN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while LIVN trades at $76.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas LIVN's P/E ratio is 18.10. In terms of profitability, INMD's ROE is +0.13%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, INMD is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for INMD.Check LIVN's competition here
Haemonetics Corporation (NYSE: HAE)
INMD vs HAE Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, HAE has a market cap of 4B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while HAE trades at $87.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas HAE's P/E ratio is 17.54. In terms of profitability, INMD's ROE is +0.13%, compared to HAE's ROE of +0.11%. Regarding short-term risk, INMD is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for INMD.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
INMD vs AXNX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas AXNX's P/E ratio is -709.80. In terms of profitability, INMD's ROE is +0.13%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, INMD is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for INMD.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
INMD vs TMDX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while TMDX trades at $83.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas TMDX's P/E ratio is 42.58. In terms of profitability, INMD's ROE is +0.13%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, INMD is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
INMD vs AXGN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while AXGN trades at $46.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas AXGN's P/E ratio is 122.18. In terms of profitability, INMD's ROE is +0.13%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, INMD is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for INMD.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
INMD vs UFPT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while UFPT trades at $314.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas UFPT's P/E ratio is 32.07. In terms of profitability, INMD's ROE is +0.13%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, INMD is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
INMD vs BFLY Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BFLY trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BFLY's P/E ratio is -36.77. In terms of profitability, INMD's ROE is +0.13%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, INMD is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
INMD vs ESTA Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ESTA trades at $77.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ESTA's P/E ratio is -61.44. In terms of profitability, INMD's ROE is +0.13%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, INMD is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
INMD vs NUVA Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas NUVA's P/E ratio is 75.00. In terms of profitability, INMD's ROE is +0.13%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, INMD is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for INMD.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
INMD vs NVCR Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while NVCR trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas NVCR's P/E ratio is -10.71. In terms of profitability, INMD's ROE is +0.13%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, INMD is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for INMD.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
INMD vs INSP Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while INSP trades at $60.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas INSP's P/E ratio is 26.51. In terms of profitability, INMD's ROE is +0.13%, compared to INSP's ROE of +0.18%. Regarding short-term risk, INMD is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for INMD.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
INMD vs TNDM Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while TNDM trades at $22.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas TNDM's P/E ratio is -20.35. In terms of profitability, INMD's ROE is +0.13%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, INMD is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for INMD.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
INMD vs ENOV Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ENOV trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ENOV's P/E ratio is 7.62. In terms of profitability, INMD's ROE is +0.13%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, INMD is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
INMD vs CNMD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CNMD trades at $49.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CNMD's P/E ratio is 10.78. In terms of profitability, INMD's ROE is +0.13%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, INMD is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
INMD vs ATEC Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ATEC trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ATEC's P/E ratio is -155.17. In terms of profitability, INMD's ROE is +0.13%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, INMD is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
INMD vs IART Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while IART trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas IART's P/E ratio is 7.31. In terms of profitability, INMD's ROE is +0.13%, compared to IART's ROE of -0.01%. Regarding short-term risk, INMD is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for INMD.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
INMD vs AORT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while AORT trades at $27.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas AORT's P/E ratio is 45.28. In terms of profitability, INMD's ROE is +0.13%, compared to AORT's ROE of -0.01%. Regarding short-term risk, INMD is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
INMD vs HSKA Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas HSKA's P/E ratio is -62.49. In terms of profitability, INMD's ROE is +0.13%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, INMD is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for INMD.Check HSKA's competition here
IRadimed Corporation (NASDAQ: IRMD)
INMD vs IRMD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while IRMD trades at $92.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas IRMD's P/E ratio is 46.48. In terms of profitability, INMD's ROE is +0.13%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, INMD is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check IRMD's competition here
Avanos Medical, Inc. (NYSE: AVNS)
INMD vs AVNS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas AVNS's P/E ratio is 27.77. In terms of profitability, INMD's ROE is +0.13%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, INMD is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for INMD.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
INMD vs PRCT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PRCT trades at $20.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PRCT's P/E ratio is -10.52. In terms of profitability, INMD's ROE is +0.13%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, INMD is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
INMD vs SILK Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SILK's P/E ratio is -18.96. In terms of profitability, INMD's ROE is +0.13%, compared to SILK's ROE of -0.35%. Regarding short-term risk, INMD is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for INMD.Check SILK's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
INMD vs LMRI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while LMRI trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas LMRI's P/E ratio is -22.53. In terms of profitability, INMD's ROE is +0.13%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, INMD is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for INMD.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
INMD vs FNA Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas FNA's P/E ratio is -19.83. In terms of profitability, INMD's ROE is +0.13%, compared to FNA's ROE of -0.35%. Regarding short-term risk, INMD is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for INMD.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
INMD vs BVS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BVS has a market cap of 956.9M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BVS trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BVS's P/E ratio is 18.59. In terms of profitability, INMD's ROE is +0.13%, compared to BVS's ROE of +0.28%. Regarding short-term risk, INMD is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BVS's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
INMD vs AVR Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, AVR has a market cap of 866.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while AVR trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas AVR's P/E ratio is -4.00. In terms of profitability, INMD's ROE is +0.13%, compared to AVR's ROE of -1.24%. Regarding short-term risk, INMD is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for INMD.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
INMD vs CSII Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CSII's P/E ratio is -20.83. In terms of profitability, INMD's ROE is +0.13%, compared to CSII's ROE of -0.14%. Regarding short-term risk, INMD is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for INMD.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
INMD vs SIBN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SIBN has a market cap of 825.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SIBN trades at $18.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SIBN's P/E ratio is -54.74. In terms of profitability, INMD's ROE is +0.13%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, INMD is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for INMD.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
INMD vs AHCO Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, AHCO has a market cap of 774.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while AHCO trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas AHCO's P/E ratio is 11.61. In terms of profitability, INMD's ROE is +0.13%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, INMD is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for INMD.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
INMD vs SSII Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SSII has a market cap of 754.5M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SSII trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SSII's P/E ratio is -73.53. In terms of profitability, INMD's ROE is +0.13%, compared to SSII's ROE of -0.23%. Regarding short-term risk, INMD is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for INMD.Check SSII's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
INMD vs BBNX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BBNX has a market cap of 715.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BBNX trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BBNX's P/E ratio is -10.53. In terms of profitability, INMD's ROE is +0.13%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, INMD is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
INMD vs CBLL Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CBLL has a market cap of 713.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CBLL trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CBLL's P/E ratio is -11.54. In terms of profitability, INMD's ROE is +0.13%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, INMD is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
INMD vs TCMD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, TCMD has a market cap of 665.4M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while TCMD trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas TCMD's P/E ratio is 33.52. In terms of profitability, INMD's ROE is +0.13%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, INMD is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check TCMD's competition here
Surmodics, Inc. (NASDAQ: SRDX)
INMD vs SRDX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SRDX's P/E ratio is -34.66. In terms of profitability, INMD's ROE is +0.13%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, INMD is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for INMD.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
INMD vs BWAY Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BWAY has a market cap of 608M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BWAY trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BWAY's P/E ratio is 39.38. In terms of profitability, INMD's ROE is +0.13%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, INMD is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
INMD vs KIDS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, KIDS has a market cap of 584.8M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while KIDS trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas KIDS's P/E ratio is -19.30. In terms of profitability, INMD's ROE is +0.13%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, INMD is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for INMD.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
INMD vs APEN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas APEN's P/E ratio is -9.43. In terms of profitability, INMD's ROE is +0.13%, compared to APEN's ROE of -0.85%. Regarding short-term risk, INMD is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for INMD.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
INMD vs CTKB Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CTKB has a market cap of 542.4M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CTKB trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CTKB's P/E ratio is -22.25. In terms of profitability, INMD's ROE is +0.13%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, INMD is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
INMD vs ZIMV Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, INMD's ROE is +0.13%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, INMD is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for INMD.Check ZIMV's competition here
Varex Imaging Corporation (NASDAQ: VREX)
INMD vs VREX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, VREX has a market cap of 522.5M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while VREX trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas VREX's P/E ratio is 13.06. In terms of profitability, INMD's ROE is +0.13%, compared to VREX's ROE of -0.18%. Regarding short-term risk, INMD is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
INMD vs DCTH Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, DCTH has a market cap of 521.6M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while DCTH trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas DCTH's P/E ratio is 1511.00. In terms of profitability, INMD's ROE is +0.13%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, INMD is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for INMD.Check DCTH's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
INMD vs NPCE Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, NPCE has a market cap of 505.6M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while NPCE trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas NPCE's P/E ratio is -25.57. In terms of profitability, INMD's ROE is +0.13%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, INMD is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for INMD.Check NPCE's competition here
Cerus Corporation (NASDAQ: CERS)
INMD vs CERS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CERS has a market cap of 473.6M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CERS trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CERS's P/E ratio is -46.91. In terms of profitability, INMD's ROE is +0.13%, compared to CERS's ROE of -0.10%. Regarding short-term risk, INMD is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CERS's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
INMD vs CLPT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CLPT has a market cap of 426.2M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CLPT trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CLPT's P/E ratio is -12.04. In terms of profitability, INMD's ROE is +0.13%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, INMD is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
INMD vs OFIX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, OFIX has a market cap of 415.5M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while OFIX trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas OFIX's P/E ratio is -13.43. In terms of profitability, INMD's ROE is +0.13%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, INMD is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check OFIX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
INMD vs SGHT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SGHT has a market cap of 406.4M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SGHT trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SGHT's P/E ratio is -13.34. In terms of profitability, INMD's ROE is +0.13%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, INMD is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
INMD vs CARL Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CARL has a market cap of 375.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CARL trades at $13.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CARL's P/E ratio is -9.66. In terms of profitability, INMD's ROE is +0.13%, compared to CARL's ROE of -0.38%. Regarding short-term risk, INMD is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
INMD vs PACB Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PACB has a market cap of 368.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PACB trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PACB's P/E ratio is -2.89. In terms of profitability, INMD's ROE is +0.13%, compared to PACB's ROE of -49.62%. Regarding short-term risk, INMD is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for INMD.Check PACB's competition here
CapsoVision, Inc. (NASDAQ: CV)
INMD vs CV Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CV has a market cap of 354.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CV trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CV's P/E ratio is -2.84. In terms of profitability, INMD's ROE is +0.13%, compared to CV's ROE of +1.27%. Regarding short-term risk, INMD is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CV's competition here
Picard Medical, Inc. (AMEX: PMI)
INMD vs PMI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PMI has a market cap of 349.2M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PMI trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PMI's P/E ratio is -2.83. In terms of profitability, INMD's ROE is +0.13%, compared to PMI's ROE of +4.99%. Regarding short-term risk, INMD is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for INMD.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
INMD vs ELMD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ELMD has a market cap of 348.5M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ELMD trades at $42.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ELMD's P/E ratio is 35.97. In terms of profitability, INMD's ROE is +0.13%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, INMD is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ELMD's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
INMD vs CATX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, CATX has a market cap of 342.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while CATX trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas CATX's P/E ratio is -2.13. In terms of profitability, INMD's ROE is +0.13%, compared to CATX's ROE of -0.42%. Regarding short-term risk, INMD is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
INMD vs SMLR Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SMLR's P/E ratio is 3.92. In terms of profitability, INMD's ROE is +0.13%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, INMD is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for INMD.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
INMD vs TMCI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, TMCI has a market cap of 308.8M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while TMCI trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas TMCI's P/E ratio is -5.06. In terms of profitability, INMD's ROE is +0.13%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, INMD is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for INMD.Check TMCI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
INMD vs SENS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, SENS has a market cap of 293.4M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while SENS trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas SENS's P/E ratio is -3.51. In terms of profitability, INMD's ROE is +0.13%, compared to SENS's ROE of -1.66%. Regarding short-term risk, INMD is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for INMD.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
INMD vs ANIK Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ANIK has a market cap of 286.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ANIK trades at $21.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ANIK's P/E ratio is 43.71. In terms of profitability, INMD's ROE is +0.13%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, INMD is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for INMD.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
INMD vs PROF Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, PROF has a market cap of 269.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while PROF trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas PROF's P/E ratio is -5.98. In terms of profitability, INMD's ROE is +0.13%, compared to PROF's ROE of -0.56%. Regarding short-term risk, INMD is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for INMD.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
INMD vs RXST Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, RXST has a market cap of 259.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while RXST trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas RXST's P/E ratio is -6.73. In terms of profitability, INMD's ROE is +0.13%, compared to RXST's ROE of -0.17%. Regarding short-term risk, INMD is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for INMD.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
INMD vs MGRM Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas MGRM's P/E ratio is -12.00. In terms of profitability, INMD's ROE is +0.13%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, INMD is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for INMD.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
INMD vs FOCL Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, FOCL has a market cap of 233.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while FOCL trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas FOCL's P/E ratio is -8.00. In terms of profitability, INMD's ROE is +0.13%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, INMD is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for INMD.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
INMD vs NVRO Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas NVRO's P/E ratio is -1.91. In terms of profitability, INMD's ROE is +0.13%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, INMD is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for INMD.Check NVRO's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
INMD vs TLSI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, TLSI has a market cap of 212.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while TLSI trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas TLSI's P/E ratio is -3.34. In terms of profitability, INMD's ROE is +0.13%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, INMD is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for INMD.Check TLSI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
INMD vs RCEL Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, RCEL has a market cap of 193M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while RCEL trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas RCEL's P/E ratio is -4.95. In terms of profitability, INMD's ROE is +0.13%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, INMD is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for INMD.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
INMD vs BSGM Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas BSGM's P/E ratio is -5.81. In terms of profitability, INMD's ROE is +0.13%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, INMD is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for INMD.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
INMD vs QTRX Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, QTRX has a market cap of 189.8M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while QTRX trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas QTRX's P/E ratio is -2.52. In terms of profitability, INMD's ROE is +0.13%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, INMD is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for INMD.Check QTRX's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
INMD vs MDGS Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas MDGS's P/E ratio is -0.27. In terms of profitability, INMD's ROE is +0.13%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, INMD is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for INMD.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
INMD vs STIM Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, STIM has a market cap of 165.6M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while STIM trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas STIM's P/E ratio is -4.41. In terms of profitability, INMD's ROE is +0.13%, compared to STIM's ROE of -1.65%. Regarding short-term risk, INMD is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for INMD.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
INMD vs INGN Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, INGN has a market cap of 163.8M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while INGN trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas INGN's P/E ratio is -6.65. In terms of profitability, INMD's ROE is +0.13%, compared to INGN's ROE of -0.13%. Regarding short-term risk, INMD is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for INMD.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
INMD vs QIPT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas QIPT's P/E ratio is -15.87. In terms of profitability, INMD's ROE is +0.13%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, INMD is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for INMD.Check QIPT's competition here
iCAD, Inc. (NASDAQ: ICAD)
INMD vs ICAD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas ICAD's P/E ratio is -20.37. In terms of profitability, INMD's ROE is +0.13%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, INMD is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for INMD.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
INMD vs OWLT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, OWLT has a market cap of 99.9M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while OWLT trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas OWLT's P/E ratio is -39.43. In terms of profitability, INMD's ROE is +0.13%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, INMD is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check OWLT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
INMD vs LUCD Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, LUCD has a market cap of 98.9M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while LUCD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas LUCD's P/E ratio is -2.61. In terms of profitability, INMD's ROE is +0.13%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, INMD is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for INMD.Check LUCD's competition here
Solana Company (NASDAQ: HSDT)
INMD vs HSDT Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, HSDT has a market cap of 98.7M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while HSDT trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas HSDT's P/E ratio is -0.02. In terms of profitability, INMD's ROE is +0.13%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, INMD is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for INMD.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
INMD vs HJLI Comparison August 2026
InMode Ltd. (NASDAQ: INMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INMD stands at 880M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, INMD is priced at $15.31 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INMD currently has a P/E ratio of 10.63, whereas HJLI's P/E ratio is N/A. In terms of profitability, INMD's ROE is +0.13%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, INMD is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for INMD.Check HJLI's competition here